Technology & Software Global On demand · 24-48h

Global Microcrystal Electron Diffraction (MicroED) Service Market Strategic Research Report

Global Microcrystal Electron Diffraction (MicroED) Service M…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Microcrystal Electron Diffraction (MicroED) Service Market
$2582025
5.6%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Single Crystal Cultivation, No Single Crystal Cultivation Required

By Application: Proteins, Small Molecules, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Creative Biostructure, CryoSol-World, ELDICO Scientific, JEOL Ltd., NanoImaging Services, NanoMEGAS SPRL, NovAliX, Oxford Instruments, ReadCrystal, Shuimu Biosciences, UniTemp GmbH, Viva Biotech, WuXi Biortus Biosciences Co. Ltd., XtalPi Inc, NanoMicro Technologies, SPERA PHARMA, Creative Bioarray, Rigaku, Triclinic Labs

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 136 pages
Market size 2025
$258
Million USD
Forecast CAGR
5.6%
2025-2032
Forecast 2032
$377.8
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Microcrystal Electron Diffraction (MicroED) Service market size is predicted to grow from US$ 258 million in 2025 to US$ 379 million in 2032; it is expected to grow at a CAGR of 5.6% from 2026 to 2032.

Microcrystal Electron Diffraction (MicroED) Service is a cryo-transmission electron microscopy (Cryo-TEM)-based nanocrystal structure resolution technology specifically designed for analyzing microcrystalline samples smaller than 1 micrometer in size that are difficult to structure using traditional X-ray diffraction or single-crystal diffraction. This service acquires diffraction data by continuously rotating the sample at extremely low electron doses under cryogenic conditions (approximately -180°C). Dedicated software (such as RED and XDS) is then used to reconstruct the three-dimensional reciprocal lattice space, accurately determining cell parameters, space group, and atomic coordinates. Its core advantages lie in its ability to resolve small organic molecules, peptides, drug cocrystals, and radiation-sensitive materials ranging from a few nanometers to submicrometers in size, with low sample requirements (micrograms) and no need to cultivate large crystals. The service workflow typically includes: microcrystal screening and cryo-sample grid preparation, cryo-EM data acquisition, automatic diffraction pattern indexing and structure refinement, and finally, delivery of a three-dimensional structural model and validation report. This technology is widely used in structural biology, drug discovery, materials chemistry, and chiral molecule identification, significantly accelerating the efficiency of structural resolution for difficult-to-crystallize molecules.

The global Microcrystal Electron Diffraction (MicroED) Service market exhibits significant regional differentiation. North America and Europe, as the originators of the technology, leverage high-end cryo-electron microscopy equipment and mature structural biology systems to lead early-stage technology development and standard setting, focusing their services on innovative drug target analysis and research on difficult-to-crystallize proteins. The Asia-Pacific region (especially China and Japan) is the core of growth, benefiting from government support for biomedical funds and the expansion of the CRO industry. Companies such as Viva Biotech and XtalPi are rapidly deploying MicroED platforms, driving service localization and cost reduction. Future trends focus on automated data acquisition, AI-assisted structural analysis, and technologies combined with cryo-electron microscopy. Major obstacles include: extremely high equipment purchase and maintenance costs (over US$2 million per microscope), a shortage of professional talent, low sample preparation success rates (especially for radiation-sensitive crystals), and insufficient data standardization.

This report presents a comprehensive overview of the global Microcrystal Electron Diffraction (MicroED) Service market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Single Crystal Cultivation
  • No Single Crystal Cultivation Required

Segment by Method

  • Rotation Method
  • Faulting Method
  • In-Situ Quenching Method
  • Others

Segment by Crystal Size

  • Crystal Size ≥ 500nm
  • Crystal Size 200-500nm
  • Crystal Size 50-200nm
  • Crystal Size 200nm-1μm

Segment by Application

  • Proteins
  • Small Molecules
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Microcrystal Electron Diffraction (MicroED) Service market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Proteins, Small Molecules, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Microcrystal Electron Diffraction (MicroED) Service Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.6%
Regional growth momentum
Market share by segment
Key metrics
Base value
$258
2025
Forecast
$377.8
2032
CAGR
5.6%
2025–2032
Regiones
5
global
Key companies
Creative BiostructureCryoSol-WorldELDICO ScientificJEOL Ltd.NanoImaging ServicesNanoMEGAS SPRLNovAliXOxford Instruments
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Single Crystal CultivationNo Single Crystal Cultivation Required
By Application
ProteinsSmall MoleculesOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Single Crystal Cultivation
  • 3.1.3 No Single Crystal Cultivation Required
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Proteins
  • 4.1.3 Small Molecules
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Creative Biostructure
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 CryoSol-World
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ELDICO Scientific
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 JEOL Ltd.
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 NanoImaging Services
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 NanoMEGAS SPRL
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 NovAliX
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Oxford Instruments
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 ReadCrystal
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Shuimu Biosciences
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 UniTemp GmbH
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Viva Biotech
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 WuXi Biortus Biosciences Co. Ltd.
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 XtalPi Inc
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 NanoMicro Technologies
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 SPERA PHARMA
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Creative Bioarray
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Rigaku
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 Triclinic Labs
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the current global Microcrystal Electron Diffraction (MicroED) Service market size?
The global Microcrystal Electron Diffraction (MicroED) Service market is estimated at US$ 258 million in 2025 (base year) and is projected to reach US$ 379 million by 2032.
What growth rate is expected for the Microcrystal Electron Diffraction (MicroED) Service market through 2032?
The market is expected to grow at a CAGR of 5.6% from 2026 to 2032, expanding from US$ 258 million in 2025 to US$ 379 million in 2032, roughly 1.5 times its base-year value.
How is Microcrystal Electron Diffraction (MicroED) Service defined?
Microcrystal Electron Diffraction (MicroED) Service is a cryo-transmission electron microscopy (Cryo-TEM)-based nanocrystal structure resolution technology specifically designed for analyzing microcrystalline samples smaller than 1 micrometer in size that are difficult to structure using traditional X-ray diffraction or single-crystal diffraction. This service acquires diffraction data by continuously rotating the sample at extremely low electron doses under cryogenic conditions (approximately -180°C).
What are the main segments of the Microcrystal Electron Diffraction (MicroED) Service market by type?
By type, the market is segmented into Single Crystal Cultivation and No Single Crystal Cultivation Required.
Which applications drive demand in the Microcrystal Electron Diffraction (MicroED) Service market?
Key applications covered include Proteins, Small Molecules and Other.
Who are the key players in the Microcrystal Electron Diffraction (MicroED) Service market?
Key players profiled include Creative Biostructure, CryoSol-World, ELDICO Scientific, JEOL Ltd., NanoImaging Services, NanoMEGAS SPRL, NovAliX and Oxford Instruments, among 19 companies covered in total.
Which regions and countries are covered for Microcrystal Electron Diffraction (MicroED) Service?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Microcrystal Electron Diffraction (MicroED) Service market?
Companies such as Viva Biotech and XtalPi are rapidly deploying MicroED platforms, driving service localization and cost reduction.
Who should buy the Microcrystal Electron Diffraction (MicroED) Service market report?
The report is intended for manufacturers and solution providers, distributors and end users in Proteins, Small Molecules and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Microcrystal Electron Diffraction (MicroED) Service market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.